Results 111 to 120 of about 418,298 (339)

Chronic fatigue syndrome: A review

open access: yesMedical Journal of Dr. D.Y. Patil University, 2014
Chronic fatigue syndrome is a disorder that is characterized by severe and debilitating fatigue of at least 6 months duration not explained on the basis of medical and psychiatric illnesses and has other associated characteristics.
Srinivas Balachander   +3 more
doaj   +1 more source

A randomized, placebo‐controlled trial of hydroxychloroquine in incomplete lupus

open access: yesArthritis &Rheumatology, Accepted Article.
Objectives Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity and incidence of SLE. Methods Hydroxychloroquine (HCQ) was chosen as an
Nancy J. Olsen   +14 more
wiley   +1 more source

Comparisons between quality of sleep and chronic fatigue syndrome in the radiology staff and nurses working in hospital

open access: yesSalāmat-i kār-i Īrān, 2017
Background and aims: sleep quality and fatigue are major aspects of human social life and can intrigue tension in healthcare workers, which ultimately causes dissatisfaction, quitting job and providing incorrect services to clients.
bahram kouhnavard   +2 more
doaj  

Skeletal muscle bioenergetics in the chronic fatigue syndrome. [PDF]

open access: bronze, 1993
P R Barnes   +3 more
openalex   +1 more source

Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell‐Targeted Therapies

open access: yesArthritis &Rheumatology, Accepted Article.
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no FDA‐approved disease‐modifying therapies for SjD.
Rachael A. Gordon, Sara S. McCoy
wiley   +1 more source

Enteroviruses and the Chronic Fatigue Syndrome [PDF]

open access: green, 1994
C.M.A. Swanink   +6 more
openalex   +1 more source

Efficacy and safety of a selective partial agonist for nociception/orphanin‐FQ peptide (NOP) receptors in patients with insomnia disorder

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Insomnia is a common sleep disorder, affecting up to 20% of the world population and adversely impacting productivity, health, and overall well‐being. Although pharmacologic options exist to treat insomnia, the health‐related quality of life for patients who are prescribed hypnotics is no higher than for those who are not, revealing a significant ...
Garth T. Whiteside   +5 more
wiley   +1 more source

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management.

open access: yesMayo Clinic proceedings, 2021
L. Bateman   +22 more
semanticscholar   +1 more source

Pregabalin dependence, withdrawal, suicidality and psychosis reports: A disproportionality analysis of the Australian adverse events database

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Globally, Australia has the highest per capita consumption rate of pregabalin, commonly prescribed for neuropathic pain. Emerging evidence suggests pregabalin may be associated with the onset or recurrence of several potentially life‐threatening psychiatric events in some individuals.
Amy G. McNeilage   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy